Meeting
2019 ASCO Annual Meeting
National cancer expenditure analysis in the United States Medicare population, 2013.
Authors
Emily S Ruiz
Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
Emily S Ruiz , Kira Seiger , Arash Mostaghimi , Chrysalyne Schmults
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Health Services Research, Clinical Informatics, and Quality of Care
Track
Quality Care/Health Services Research
Sub Track
Value/Cost of Care
Citation
J Clin Oncol 37, 2019 (suppl; abstr 6647)
DOI
10.1200/JCO.2019.37.15_suppl.6647
Abstract #
6647
Poster Bd #
444
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Genitourinary Cancers Symposium
Long-term cost comparisons of radical cystectomy versus trimodal therapy for muscle-invasive bladder cancer.
First Author: Vishnukamal Golla
Poster
2016 Genitourinary Cancers Symposium
Docetaxel chemotherapy in metastatic castration-resistant prostate cancer (mCRPC): Cost of care for Medicare and commercially insured men.
First Author: Andrew J. Armstrong
Poster
2011 ASCO Annual Meeting
Managing specialty medication services through a network of specialty pharmacies: A case of oral oncology medications.
First Author: S. Aslam
Poster
2024 ASCO Annual Meeting
Systemic anti-cancer therapy and cost at end of life: A SEER Medicare analysis.
First Author: Kerin B. Adelson